1. Latest News
  2. Submit Press Release

Maximise manufacturing efficiency and scale-ability for miniaturisation and bead milling

Examining the latest developments in nanomedicine and enhancing in vivo circulation time, extending dissolution kinetics, and improving delivery with drug-porous nanocarriers, lipid-based compounds and biologics.

Feb. 10, 2012 - PRLog -- With a month to go join SMi at their 9th annual Controlled Release conference to be held on the 28th & 29th March 2012 London. This must-attend event will once again lead the way in examining the latest developments in nanomedicine and featuring fresh presentations from companies including GlaxoSmithKline, Lundbeck, Merck Serono and Genzyme.

Controlled Release will allow delegates to meet and network with key decision makers from the top pharmaceutical companies, as well as discuss & debate current issues such as challenges in drug formulation for oral delivery - where are we and what are the prospects for the future, challenges and opportunities for delivering biologics to the CNS and solutions for dissolution testing of non-oral formulations.

Network with key presenters within the pharmaceutical industry that includes:

•   Peter Timmins, Executive Director, Drug Products, Science and Technology, Bristol-Myers Squibb
•   Mark Wilson, Director, Collaboration Management, GlaxoSmithkline
•   Simon Holland, Director, Process Understanding & Control, GlaxoSmithKline
•   Bernd Riebesehl, Principal Fellow, Parenteral Dosage Forms, Pharmaceutical and Analytical Development, Novartis
•   Mostafa Nakach, Head of the Pharmaceutical Engineering Group, Sanofi-Aventis
•   Michael Keller, Senior Fellow, siRNA Project Leader, Technical Research and Development (TRD), Novartis
•   Jonathan Brown, Senior Research Investigator, Bristol-Myers Squibb
•   Tomas Landh, Director, Novo Nordisk
•   Jan L. Powell, Director, Physiology, Shire HGT
•   Lars Bauer, Senior Medical Director, Therapeutic Area CNS, UCB
•   Karin Liltorp, Director, Preformulation, Lundbeck

Visit http://www.smi-online.co.uk/controlledrelease48.asp for more information or to register your place. Alternatively, contact Fateja Begum at Tel: +44 (0) 207 827 6184 or Email: fbegum@smi-online.co.uk

--- End ---

Click to Share

Contact Email:
***@smi-online.co.uk Email Verified
Source:SMi Group
Location:United Kingdom
Tags:Formulation, Drug Delivery, Transderal, Occular, Microbicide, Parenteral, Lipsomal, Nanocrystal
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share